ascular Surgery
January Supplement 2022

144. Robless PA, Tegos TJ, Okonko D, Mansﬁeld AO, Nicolaides AN,
Mikhailidis DP, et al. Platelet activation during carotid endarterectomy and the antiplatelet effect of Dextran 40. Platelets 2002;13:
231-9.
145. Jones CI, Payne DA, Hayes PD, Naylor AR, Bell PR, Thompson MM,
et al. The antithrombotic effect of dextran-40 in man is due to
enhanced ﬁbrinolysis in vivo. J Vasc Surg 2008;48:715-22.
146. Farber A, Tan TW, Rybin D, Kalish JA, Hamburg NM, Doros G, et al.
Intraoperative use of dextran is associated with cardiac complications after carotid endarterectomy. J Vasc Surg 2013;57:635-41.
147. Asiddao CB, Donegan JH, Whitesell RC, Kalbﬂeisch JH. Factors
associated with perioperative complications during carotid endarterectomy. Anesth Analg 1982;61:631-7.
148. Towne JB, Bernhard VM. The relationship of postoperative hypertension to complications following carotid endarterectomy. Surgery
1980;88:575-80.
149. Payne DA, Twigg MW, Hayes PD, Naylor AR. Antiplatelet agents and
risk factors for bleeding postcarotid endarterectomy. Ann Vasc Surg
2010;24:900-7.
150. Naylor AR, Evans J, Thompson MM, London NJ, Abbott RJ,
Cherryman G, et al. Seizures after carotid endarterectomy: hyperperfusion, dysautoregulation or hypertensive encephalopathy? Eur
J Vasc Endovasc Surg 2003;26:39-44.
151. Wijeysundera DN, Duncan D, Nkonde-Price C, Virani SS,
